Search results for " organizations"

showing 10 items of 835 documents

In Which Type of Healthcare Do Patients Show Greater Loyalty? (Public Sector Management vs. Public-Private Partnership)

2018

Introduction: The present study analyses the patients behavior in a setting with different management types: public sector management and public-private partnership. More specifically, the objective is to establish in which healthcare type (hospitalization, ambulatory surgery, emergencies, outpatients consultation) do the patients show a loyal behavior when they are in different management scenarios. Material and methods: A descriptive analysis based on secondary data collected from an internal database of the Conselleria de Sanidad of the Valencian Community in Spain, a scenario with two different healthcare management types (public sector management and public-private partnership) was con…

healthcare services managementmedicine.medical_specialtyHealth (social science)media_common.quotation_subjectlcsh:MedicineMedicine (miscellaneous)Public administrationHealth administrationLoyaltyHealth caremedicinehealth care economics and organizationsmedia_commonlcsh:R5-920business.industryPublic healthlcsh:RPublic sectorPrivate sectorconsumer behavior.Public–private partnershiphealthcare services marketingGeneral partnershipPatients’ loyalty behaviourlcsh:Medicine (General)businessRevista Ciencias de la Salud
researchProduct

Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort

2017

We evaluated the cost-effectiveness of two alternative direct-acting antiviral (DAA) treatment policies in a real-life cohort of hepatitis C virus–infected patients: policy 1, “universal,” treat all patients, regardless of fibrosis stage; policy 2, treat only “prioritized” patients, delay treatment of the remaining patients until reaching stage F3. A liver disease progression Markov model, which used a lifetime horizon and health care system perspective, was applied to the PITER cohort (representative of Italian hepatitis C virus–infected patients in care). Specifically, 8,125 patients naive to DAA treatment, without clinical, sociodemographic, or insurance restrictions, were us…

hepatitis C virusPediatricsCost effectivenessViral HepatitisAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models Economic; HepatologyCost-Benefit AnalysisDirect-acting antiviralAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models EconomicCohort StudiesLiver disease0302 clinical medicineModelsHealth careantiviral therapy80 and overincremental cost-effectiveness ratiohealth care economics and organizationsHCV cost -effectivenessAged 80 and overDirect-acting antiviral hepatocellular carcinoma hepatitis C virus incremental cost-effectiveness ratio interferon quality-adjusted life-years sustained virological response willingness to payCost–benefit analysis030503 health policy & servicesquality-adjusted life-yearsHealth PolicyHepatitis Chepatocellular carcinomainterferonMiddle AgedHepatitis CModels EconomicAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models Economic; Hepatology; HCV; antiviral therapy; cost-effectiveness; real-life cohortCohortHCV030211 gastroenterology & hepatologyOriginal Articlesustained virological response0305 other medical scienceCohort studyHumanAdultmedicine.medical_specialtyEconomicAntiviral AgentsNO03 medical and health sciencesYoung Adultreal-life cohortmedicineHumansCost-Benefit Analysicost-effectivenessHealth policyAgedAntiviral AgentHepatologybusiness.industryOriginal Articlesmedicine.diseaseSurgeryCohort Studiebusinesswillingness to pay
researchProduct

Agrupaciones autónomas de personas ante el impuesto sobre el valor añadido

2021

This work carries out the delimitation of the exemption in the European V.A.T., of the benefits made to its members, by the autonomous groups of people, highlighting the distinctions made by the community case law, with particular attention to the subjective element of the exemption.

highlighting the distinctions made by the community case law:CIENCIAS JURÍDICAS [UNESCO]with particular attention to the subjective element of the exemption. Agrupación autónoma de personasEnrique de This work carries out the delimitation of the exemption in the European V.A.T.I.V.A.2070-8157 22082 Revista Boliviana de Derecho 584568 2021 32 8055233 Agrupaciones autónomas de personas ante el impuesto sobre el valor añadido Miguel Canutoof the benefits made to its membershumanitiesV.A.T. 618 649UNESCO::CIENCIAS JURÍDICASby the autonomous groups of peopleIndependent group of personshealth care economics and organizations
researchProduct

Human neonatal responses to androstenone

2010

Poster P327 session VII: Olfactory Psychophysics & Clinical Studies; Central Olfaction; Aims. Human newborns show equal attraction to the odors of amniotic. fluid (AF) and mothers’ colostrum [1]. As 5-a-androst-16-en-3-. one (An) has been found in both fluids [2, 3], we studied it as a. potential vector of this perinatal odor continuity and of neonatal. attraction to the smell of breast and milk [4]. Methods. Two studies. were run. 1) We recorded the behavior of 16 newborns (3 days) and. 26 adults exposed to a saturating water solution of An and to 3. reference odorants [butyric acid, B; vanilla, V; water, W]. 2) We videotaped. 26 newborns (3 days) being administered 7 stimuli: 4 dilution. …

human newborn[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionodor[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionandrostenoneeducationfacial responsehuman activities[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionhealth care economics and organizationsolfaction
researchProduct

A scoping review exploration of the intended and unintended consequences of eHeath on older people : a health equity impact assessment

2018

eHealth is one perceived mechanism to extend the range and reach of limited health-care resources for older adults. A decade-scoping review (2007–2017) was conducted to systematically search and synthesize evidence to understand the intended and unintended consequences of eHealth initiatives, informed by a health equity impact assessment framework. Scoping review sources included international academic and grey literature on eHealth initiatives (e.g., eHealth records, telemedicine/telecare, and mobile eHealth application) focused on the varying needs of older adults (aged 60+), particularly individuals experiencing sociocultural and economic difficulties. Findings suggest that eHealth has s…

ikääntyminenhealth services administrationhealth care facilities manpower and servicesterveydenhuoltoeducationaging and technologyteknologiaeHealthscoping reviewhealth equity impact assessmenthealth care economics and organizationsolder adultsikääntyneet
researchProduct

First-Line Treatments for Extensive-Stage Small-Cell Lung Cancer With Immune Checkpoint Inhibitors Plus Chemotherapy: A Network Meta-Analysis and Cos…

2022

BackgroundImmune checkpoint inhibitors (ICIs) plus chemotherapy were unlikely to be considered cost-effective compared with chemotherapy as the first-line treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) in China due to its high costs. However, the cost-effectiveness of the comparison between the regimens of ICIs plus chemotherapy were remained unclear yet. The aim of this study was to evaluate the efficacy and cost-effectiveness of ICIs plus chemotherapy as the first-line treatment for ES-SCLC from the perspective of the Chinese healthcare system.MethodsA network meta-analysis (NMA) was conducted to indirect compare the clinical benefits between the ICIs plus che…

immune checkpoint inhibitorsCancer ResearchOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogenschemotherapyextensive-stage small-cell lung cancercost-effectivenessfirst-line treatmenthealth care economics and organizationsRC254-282Original ResearchFrontiers in Oncology
researchProduct

Additional file 3: Figure S2. of Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resi…

2017

Krona visualisation of the relative abundance of intestinal bacterial OTUs identified in fish fed D1. (HTML 238 kb)

information sciencenatural scienceshealth care economics and organizations
researchProduct

Additional file 6: Figure S5. of Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resi…

2017

Krona analysis of the relative abundance of intestinal bacterial OTUs identified in fish fed D4. (HTML 250 kb)

information sciencenatural scienceshealth care economics and organizations
researchProduct

Additional file 6: Figure S5. of Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resi…

2017

Krona analysis of the relative abundance of intestinal bacterial OTUs identified in fish fed D4. (HTML 250 kb)

information sciencenatural scienceshealth care economics and organizations
researchProduct

Additional file 4: Figure S3. of Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resi…

2017

Krona analysis of the relative abundance of intestinal bacterial OTUs identified in fish fed D2. (HTML 243 kb)

information sciencenatural scienceshealth care economics and organizations
researchProduct